Samuel T. Lockner

Jennell C. Bilek

Caroline L. Marsili

Anne S. Gaza

Samantha G. Wilson

Mitchell R. Williams

Jack B. Blumenfeld

Jennifer H. Roscetti

Megan Dellinger

Danielle A. Duszczyszyn

Jeremy A. Tigan

William B. Raich

Ryan McDonnell

Constance Pei Hwa Lee

Reinaldo F. Machin

ANDA filing sparks second lawsuit as AbbVie challenges Sun Pharma's generic ORILISSA®, citing new patent claims on a high-purity `composition` and impurity levels.

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Judge	Period	PO Win Rate
Jennifer L. Hall	01/09/24 - 06/21/24	28%
Richard G. Andrews	06/28/23 - 01/09/24	36%

Name	Ratings
AbbVie Inc	L5 E
AbbVie US LLC	L5 E

Name	Ratings
Morris Nichols Arsht & Tunnell LLPLocal	L5 A
Jack B. Blumenfeld	L5 A
Jeremy A. Tigan	L5 B
Megan Dellinger	L3 A
Finnegan Henderson Farabow Garrett & Dunner LLP	L5 B
Jennifer H. Roscetti	L3 B
William B. Raich	L2 A
Danielle A. Duszczyszyn	L2 C
Constance Pei Hwa Lee	L1 C
Ryan McDonnell	L1 D
Reinaldo F. Machin	-- -- --

Name	Ratings
Young Conaway Stargatt & Taylor LLPLocal	L5 E
Anne S. Gaza	L4 B
Samantha G. Wilson	L3 B
Carlson Caspers Vandenburgh Lindquist Schuman PA	L3 C
Samuel T. Lockner	L4 E
Caroline L. Marsili	L2 D
Jennell C. Bilek	L2 E
Mitchell R. Williams	-- -- --

1:23-cv-00684

AbbVie Inc v. Sun Pharmaceutical Industries Ltd